CODX
Co-Diagnostics, Inc.
1.25
USD
This page is just a preview of the data found in TrendSpider’s full version
Co-Diagnostics, Inc. stock is up 9.65% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 28.57% of the previous 6 December’s closed higher than November. 0% of analysts rate it a buy.
Co-Diagnostics, Inc. develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and analysis of nucleic acid molecules. Company also provides tests that identify genetic traits in plant and animal genomes. Company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
